The intervention being tested is Avacopan, an oral medication intended to provide long-term treatment for ANCA-associated vasculitis. The study includes three groups: one receiving Avacopan with ...

Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have a significantly higher overall risk of developing cancer, according to a systematic review and meta-analysis ...

Patients with AAV and kidney involvement who take SGLT-2 inhibitors may have a reduced risk for ESRD and kidney transplant ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is currently conducting a Phase 3 ...

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals recently ...

Vasculitis sydromes are a group of autoimmune disorders characterized by inflammation of the blood vessels, either primary or secondary to another condition. The different vasculitis syndromes are ...

“Carrie’s contributions as Chairman of the Board have been instrumental in advancing Descartes-08 to where it is today,” said Dr. Brunn. “We are grateful for her knowledge and guidance over the years, ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the first results from the open-label extension trial of the Phase 3 GATHER2 study, which demonstrated ...

ORLANDO -- The investigational interleukin (IL)-6 inhibitor vamikibart led to visual improvements in uveitic macular edema in ...

Biogen gains exclusive rights to Vanqua's oral C5aR1 antagonist, boosting its immunology pipeline with potential across ...

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® ...

Ajertil, A., Jirari Rim, M’Benga. L.-J.K. and El Quessar, A. (2025) Severe and Rare Cerebrovascular Involvement in Systemic Lupus Erythematosus: Case Report and Literature Review. Open Access Library ...